Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 29;10(1):21.
doi: 10.1186/s13756-021-00893-z.

Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?

Eric Pelfrene  1 , Radu Botgros  2 , Marco Cavaleri  2
Affiliations

Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?

Eric Pelfrene et al. Antimicrob Resist Infect Control. .

Abstract

Background: Antimicrobial resistance (AMR) is a growing global problem to which the ongoing COVID-19 pandemic may further contribute. With resources deployed away from antimicrobial stewardship, evidence of substantial pre-emptive antibiotic use in COVID-19 patients and indirectly, with deteriorating economic conditions fuelling poverty potentially impacting on levels of resistance, AMR threat remains significant.

Main body: In this paper, main AMR countermeasures are revisited and priorities to tackle the issue are re-iterated. The need for collaboration is stressed, acknowledging the relationship between human health, animal health and environment ("One Health" approach). Among the stated priorities, the initiative by the European Medicines Regulatory Network to further strengthen the measures in combatting AMR is highlighted. Likewise, it is asserted that other emerging health threats require global collaboration with the One Health approach offering a valuable blueprint for action.

Conclusion: The authors stress the importance of an integrated preparedness strategy to tackle this public health peril.

Keywords: Antibiotics; Antimicrobial resistance; Antimicrobial stewardship; COVID-19; Coronaviruses; One health; Pandemic; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. European Medicines Agency. Availability of medicines during COVID-19 pandemic. Amsterdam: European Medicines Agency; 2020. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-thr.... Accessed 26 Nov 2020.
    1. World Health Organization. Record number of countries contribute data revealing disturbing rates of antimicrobial resistance (1 June 2020). Geneva: World Health Organization; 2020. https://www.who.int/news-room/detail/01-06-2020-record-number-of-countri.... Accessed 26 Nov 2020.
    1. Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in Northeast Chongqing. J Med Virol. 2020;92:797–806. doi: 10.1002/jmv.25783. - DOI - PMC - PubMed
    1. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-1 antimicrobial prescribing. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa530. - DOI - PMC - PubMed
    1. Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976. doi: 10.1001/jamanetworkopen.2020.3976. - DOI - PMC - PubMed

MeSH terms

Substances